Edap Tms (NASDAQ:EDAP) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why

Edap Tms S.A. (NASDAQ:EDAP)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.83 and traded as high as $2.33. Edap Tms shares last traded at $2.20, with a volume of 58,955 shares changing hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Edap Tms in a research report on Saturday, September 27th. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $8.50.

Edap Tms Trading Down 3.9%

The company has a market cap of $82.26 million, a price-to-earnings ratio of -3.61 and a beta of -0.15. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.05 and a current ratio of 1.51. The business’s 50 day moving average price is $1.99 and its 200-day moving average price is $1.83.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Banque Transatlantique SA raised its holdings in shares of Edap Tms by 7,063.7% in the 1st quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider’s stock worth $1,324,000 after buying an additional 720,499 shares in the last quarter. Scoggin Management LP acquired a new position in shares of Edap Tms in the 1st quarter worth approximately $686,000. Sage Mountain Advisors LLC acquired a new position in Edap Tms during the second quarter worth $165,000. Millennium Management LLC raised its stake in Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 33,558 shares in the last quarter. Finally, Simplicity Wealth LLC acquired a new position in Edap Tms during the second quarter worth $54,000. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.